PANTHER Trademark

Trademark Overview

On Wednesday, June 19, 2024, a trademark application was filed for PANTHER with the United States Patent and Trademark Office. The USPTO has given the PANTHER trademark a serial number of 98608631. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, June 27, 2025. This trademark is owned by Panther Life Sciences Coproration. The PANTHER trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information related to immune system modulation through the use of microarray patches
panther

General Information

Serial Number98608631
Word MarkPANTHER
Filing DateWednesday, June 19, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, June 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical information related to immune system modulation through the use of microarray patches

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 19, 2024
Primary Code044
First Use Anywhere DateThursday, March 2, 2023
First Use In Commerce DateThursday, March 2, 2023

Trademark Owner History

Party NamePanther Life Sciences Coproration
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNORMANDY PARK, WA 98166

Trademark Events

Event DateEvent Description
Wednesday, June 19, 2024NEW APPLICATION ENTERED
Wednesday, June 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 20, 2024ASSIGNED TO EXAMINER
Saturday, December 21, 2024NON-FINAL ACTION WRITTEN
Saturday, December 21, 2024NON-FINAL ACTION E-MAILED
Saturday, December 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2025NON-FINAL ACTION WRITTEN
Tuesday, January 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 10, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2025NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 10, 2025FINAL REFUSAL WRITTEN
Monday, February 10, 2025FINAL REFUSAL E-MAILED
Friday, March 7, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 4, 2025NON-FINAL ACTION WRITTEN
Friday, April 4, 2025NON-FINAL ACTION E-MAILED
Friday, April 4, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 27, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, June 27, 2025EXAMINER'S AMENDMENT ENTERED
Friday, June 27, 2025EXAMINERS AMENDMENT E-MAILED
Friday, June 27, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

panther modulation through microarray patches system immune medical information related providing